SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005262
Filing Date
2021-04-29
Accepted
2021-04-29 16:18:24
Documents
93
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20210331x10q.htm   iXBRL 10-Q 1811432
2 EX-10.1 bpmc-20210331xex10d1.htm EX-10.1 167603
3 EX-31.1 bpmc-20210331xex31d1.htm EX-31.1 11755
4 EX-31.2 bpmc-20210331xex31d2.htm EX-31.2 11833
5 EX-32.1 bpmc-20210331xex32d1.htm EX-32.1 10661
  Complete submission text file 0001558370-21-005262.txt   7625459

Data Files

Seq Description Document Type Size
6 EX-101.SCH bpmc-20210331.xsd EX-101.SCH 62494
7 EX-101.CAL bpmc-20210331_cal.xml EX-101.CAL 59501
8 EX-101.DEF bpmc-20210331_def.xml EX-101.DEF 217638
9 EX-101.LAB bpmc-20210331_lab.xml EX-101.LAB 482757
10 EX-101.PRE bpmc-20210331_pre.xml EX-101.PRE 428115
11 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20210331x10q_htm.xml XML 1260316
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 21870888
SIC: 2834 Pharmaceutical Preparations